Trial Profile
A Study to Evaluate the Usefulness of Sputum Eosinophilia as Marker of the Efficacy Of Omalizumab Treatment in Patients With Severe Allergic Asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2016
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 16 Jan 2016 New trial record